18371219

Source:http://linkedlifedata.com/resource/pubmed/id/18371219

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0013216, umls-concept:C0026882, umls-concept:C0036667, umls-concept:C0312418, umls-concept:C1306673
pubmed:issue	2
pubmed:dateCreated	2008-5-29
pubmed:abstractText	In vitro evidence suggests that PIK3CA (phosphatidylinositol 3-kinase, catalytic, alpha polypeptide) activation may be associated with altered chemotherapy sensitivity in cancer.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/2P30CA016672 28, http://linkedlifedata.com/resource/pubmed/grant/R01-CA106290
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-10769688, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-10963602, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-11553815, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-12611463, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-12761490, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-12838322, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-15016963, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-15254419, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-15520168, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-15608678, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-15805248, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-15837735, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-15863375, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-16168105, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-16432179, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-16516442, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-16896004, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-17059381, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-17314276, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-17561399, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-17602071, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-17703603, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-17785706, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-17947469, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-18258986, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-2174051, http://linkedlifedata.com/resource/pubmed/commentcorrection/18371219-2833705
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100927353
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anthracyclines, http://linkedlifedata.com/resource/pubmed/chemical/PIK3CA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status	MEDLINE
pubmed:issn	1465-542X
pubmed:author	pubmed-author:BardelliAlbertoA, pubmed-author:CardoneLucaL, pubmed-author:FigureoaLuis J BarajasLJ, pubmed-author:GomezHenry LHL, pubmed-author:HortobagyiGabriel NGN, pubmed-author:HubbardRebekah ERE, pubmed-author:LiedtkeCorneliaC, pubmed-author:PusztaiLajosL, pubmed-author:ReeT STS, pubmed-author:SouchonEduardo AEA, pubmed-author:SymmansW FraserWF, pubmed-author:TordaiAttilaA, pubmed-author:ValeroVicenteV
pubmed:issnType	Electronic
pubmed:volume	10
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	R27
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:18371219-Adult, pubmed-meshheading:18371219-Aged, pubmed-meshheading:18371219-Anthracyclines, pubmed-meshheading:18371219-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18371219-Breast Neoplasms, pubmed-meshheading:18371219-Chemotherapy, Adjuvant, pubmed-meshheading:18371219-DNA Mutational Analysis, pubmed-meshheading:18371219-Female, pubmed-meshheading:18371219-Humans, pubmed-meshheading:18371219-Lymphatic Metastasis, pubmed-meshheading:18371219-Middle Aged, pubmed-meshheading:18371219-Mutation, pubmed-meshheading:18371219-Neoadjuvant Therapy, pubmed-meshheading:18371219-Neoplasm Staging, pubmed-meshheading:18371219-Phosphatidylinositol 3-Kinases, pubmed-meshheading:18371219-Receptor, erbB-2, pubmed-meshheading:18371219-Receptors, Estrogen, pubmed-meshheading:18371219-Receptors, Progesterone, pubmed-meshheading:18371219-Taxoids, pubmed-meshheading:18371219-Tumor Markers, Biological
pubmed:year	2008
pubmed:articleTitle	PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer.
pubmed:affiliation	Department of Breast Medical Oncology, University of Texas M, D, Anderson Cancer Center, Houston, TX, USA.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural